DHIA
ARM & HAMMER Prepares Industry for FDA Guidance #263
In June 2021, the Food and Drug Administration (FDA) finalized guidance for industry (GFI) #263, a directive that recommends sponsors of “medically important” antimicrobial drugs that are currently approved with over the counter (OTC) marketing [Read More …]
